✦ LIBER ✦

Influence of amifostine (A) on the toxicity and pharmacokinetics (PK) of docetaxel (D) in breast cancer patients: An EORTC-IDBBC study

✍ Scribed by D. de Valeriola; A. Awada; A. Van Vreckem; N. Habboubi; A. Riva; M. Piccart

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

710 - Docetaxel (D) in combination with

✍ A. Awada; D. de Valériola; N. Cornez; J. Kerger; A. Van Vreckem; S. Bartholomeus 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 216 KB

An EORTC-IDBBC phase I study of gemcitab

✍ A Awada; L Biganzoli; T Cufer; L Beex; C Lohrisch; V Batter; A Hamilton; M Nooij 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Sequence effect of docetaxel and carbopl

✍ Maki Ando; Hideo Saka; Yuichi Ando; Hironobu Minami; Takafumi Kuzuya; Masashi Ya 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 284 KB

Influence of pharmacogenetics on respons

✍ Bray, J; Sludden, J; Griffin, M J; Cole, M; Verrill, M; Jamieson, D; Boddy, A V 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 367 KB

The SUCCESS-Trial -toxicity analysis of

✍ W. Janni; E. Genss; B. Rack; H. Sommer; M. Rezai; A. Schneider; W. Lichtenegger; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Cyclophosphamide (C) - Epirubicine (E) -

✍ L. Biganzoli; H. Bonnefoi; L. Mauriac; T. Cufer; E. Ngalula Kabanga; D. Hébert; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB